Dr. László Tabár[email protected]Clinical NewsOpinion: Stop misleading women on breast screeningThe article published 5 July by JAMA Oncology about the cost-effectiveness of breast screening is another example of the type of "nonscience" from a leading tabloid journal, writes Dr. László Tabár. Women and decision-makers deserve correct and honest information, and it's time to focus on the harm of not being screened, he notes.July 5, 2018Clinical NewsMammography's alleged harms: Separating fact from fictionScreening mammography is a tool that has been proved to reduce breast cancer death rates, but its effectiveness continues to be disputed by researchers, some of whom have resorted to guesswork to buttress their arguments, according to an opinion piece by mammography experts Dr. László Tabár and Dr. Peter B. Dean.December 13, 2012Clinical NewsAnalysis of Swedish county data is off the markIn this week's study in the Journal of the National Cancer Institute, a research team claimed to find that mammography screening had no impact on mortality from breast cancer, based on their interpretation of data from Swedish counties. However, the group made a number of fatal mistakes in their analysis, according to Dr. László Tabár.July 16, 2012Page 1 of 1Top StoriesRöKo 2026Röko 2026: "Europe as stress test for healthcare innovation""The real bottleneck today is no longer whether AI works technically," Mathias Goyen, Global Chief Medical Officer for Imaging at GE HealthCare, said at RöKo 2026. "The bottleneck is whether healthcare systems can adapt organizationally, financially, and politically fast enough to integrate it into routine care."HomeRöKo 2026: „Europa als Stresstest für Innovation im Gesundheitswesen"RöKo 2026Video: Marcus Katoh über Hands-on-Training beim RöKo 2026RöKo 2026Video: Marcus Katoh on hands-on training at RöKo 2026Sponsor ContentWe're Covering ROKO 2026 - Live from Germany
